No clinically relevant differences between positron emission tomography (PET) reconstructions based on low-dose or contrast-enhanced CT in combined integrated multiphase18F-Fluorethylcholine PET/CT for prostate cancer
- 13 June 2016
- journal article
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 60 (4) , 498-505
Abstract
There is no clinically relevant difference between reconstruction of PET images based on ceCT or neCT in FCH-PET/CT in patients with prostate cancer. Small quantitative differences exist, but do not lead to clinically relevant differences in visual quality or clinical assessment of patients. Therefore, CT scan may be used for attenuation correction.Keywords
Funding Information
- Bayer
This publication has 22 references indexed in Scilit:
- Gleason Score at Diagnosis Predicts the Rate of Detection of 18F-Choline PET/CT Performed When Biochemical Evidence Indicates Recurrence of Prostate Cancer: Experience with 1,000 PatientsJournal of Nuclear Medicine, 2014
- EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate CancerEuropean Urology, 2014
- Role of 18F-choline PET/CT in suspicion of relapse following definitive radiotherapy for prostate cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Contrast medium injection protocol adjusted for body surface area in combined PET/CTEuropean Radiology, 2013
- Different Intravenous Contrast Media Concentrations Do Not Affect Clinical Assessment of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scans in an Intraindividual ComparisonInvestigative Radiology, 2012
- PET/CT in lung cancer: Influence of contrast medium on quantitative and clinical assessmentEuropean Radiology, 2012
- Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT scans for diagnosing ovarian cancer recurrenceEuropean Journal of Radiology, 2012
- Performance of integrated FDG–PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG–PET/non-contrast-enhanced CT and enhanced CTEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imagingBritish Journal of Radiology, 2007
- Effects of Nonionic Intravenous Contrast Agents at PET/CT Imaging: Phantom and Canine StudiesRadiology, 2003